Rapport

DRC Equity Accelerator Fund: Cost-Effectiveness Evaluation Report

This report evaluates the cost-effectiveness of two complementary Gavi Equity Accelerator Fund interventions, the Next Generation Supply Chain Initiative (NGCA) and door-to-door vaccination, delivered as a bundled package in Tshopo and Haut-Katanga provinces, DRC. Using a pre/post design across 60 sampled health areas and a micro-costing approach from a health systems perspective, the study found that the package vaccinated 5,157 additional zero-dose children (+24%, p < .001) and delivered 18% more Penta-1 doses. The incremental cost was US$23.77 per additional zero-dose child, and the package cost US$85.75 per DALY averted, below the 1× GDP per capita threshold of US$806.80. Transportation was the largest cost driver, at 41% of endline costs. Limitations include the absence of a control group, the inability to separate the effects of the two components, reliance on routine DHIS2 data, and a DALY estimate based on only two of the five diseases the pentavalent vaccine protects against. The report offers cost benchmarks for budgeting equity-focused immunization and recommends planning a transition to government financing.

Was this useful?
Log in to vote

Ajouté par: VillageReach

Ajouté le: 2026-11-16 15:56:53

Consultations: 11

Fichier téléchargé

VR_CostEffectivenessReport_FINAL.pdf

Cliquez pour télécharger